Alimentiv Revenue and Competitors
Estimated Revenue & Valuation
- Alimentiv's estimated annual revenue is currently $123M per year.
- Alimentiv's estimated revenue per employee is $201,000
Employee Data
- Alimentiv has 612 Employees.
- Alimentiv grew their employee count by 5% last year.
Alimentiv Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.8M | 34 | -41% | N/A | N/A |
#2 | $88M | 438 | 9% | N/A | N/A |
#3 | $86.8M | 432 | 24% | N/A | N/A |
#4 | $53.1M | 264 | 0% | N/A | N/A |
#5 | $1.2M | 6 | 0% | N/A | N/A |
#6 | $14.3M | 71 | 6% | N/A | N/A |
#7 | $43.8M | 218 | 6% | N/A | N/A |
#8 | $2.2M | 11 | 0% | N/A | N/A |
#9 | $23.3M | 116 | 6% | N/A | N/A |
#10 | $36.2M | 180 | 31% | N/A | N/A |
What Is Alimentiv?
From 1986 to 2020 we operated as Robarts Clinical Trials and built a strong foundation in the medical research community. In 2020, we became Alimentiv but retained our commitment to clinical trials, medical imaging, and precision medicine for GI-related ailments.
keywords:N/A
N/A
Total Funding
612
Number of Employees
$123M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alimentiv's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Manager, Human Resources | Reveal Email/Phone |
2 | Manager, Statistics and Statistical Programming | Reveal Email/Phone |
3 | Senior Project Director | Reveal Email/Phone |
4 | Project Coordinator | Reveal Email/Phone |
5 | Senior Clinical Translational Scientist | Reveal Email/Phone |
6 | Director Project Management | Reveal Email/Phone |
7 | IRT Manager | Reveal Email/Phone |
8 | Project Manager | Reveal Email/Phone |
9 | Senior Clinical Research Associate | Reveal Email/Phone |
10 | VP, People and Culture | Reveal Email/Phone |
Alimentiv News
2022-04-13 - Helmsley Charitable Trust awards $5.3 million to Cleveland ...
Brian Feagan, senior scientific director at Alimentiv. Despite advances in the treatment of gut inflammation, a lack of appropriate biomarkers...
2022-04-06 - Difficult-to-treat inflammatory bowel disease: results from a ...
LP-B reports personal fees from Galapagos, AbbVie, Janssen Pharmaceuticals, Genentech, Alimentiv, Ferring Pharmaceuticals, Tillots Pharma, Celltrion, Takeda,...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $160.9M | 613 | N/A | N/A |
#2 | $101.4M | 614 | 9% | $160.2M |
#3 | $188M | 614 | N/A | N/A |
#4 | $35M | 614 | -21% | N/A |
#5 | $186.5M | 614 | 5% | N/A |